Overview

lapatinib


'lapatinib' can also refer to...

lapatinib

Lapatinib in breast cancer

Phase II study on lapatinib in advanced EGFR-positive chordoma†

Assay of lapatinib in murine models of cigarette smoke carcinogenesis

Lapatinib Study Supports Cancer Stem Cell Hypothesis, Encourages Industry Research

Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)

Lapatinib Moves Forward in Inflammatory and Early HER2-Positive Breast Cancer Trials

PLS-1A JAPANESE SUBGROUP ANALYSIS OF THE LAPATINIB FOR GASTRIC CANCER (TYTAN) STUDY

Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib

28LAPATINIB IN EGYPTIAN WOMEN WITH METASTATIC BREAST CANCER: IN WHICH DOSE AND AT WHAT FREQUENCY?

47PGENOME-WIDE DNA COPY NUMBER PROFILES IDENTIFY LAPATINIB SENSITIVITY IN METASTATIC BREAST CANCER PATIENTS

O2–043RETROSPECTIVE ANALYSIS OF EFFICACY AND OPTIONAL TREATMENT WITH LAPATINIB PLUS CAPECITABINE THERAPY

P-0014INSULIN RECEPTOR ACTIVATION CONFERS RESISTANCE TO LAPATINIB INHIBITION IN HER2-POSITIVE GASTRIC CANCER

ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma†

Effect of Lapatinib on the Development of Estrogen Receptor–Negative Mammary Tumors in Mice

Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib

 

More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Quick Reference

A dual inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) tyrosine kinases, used in combination with capecitabine for the treatment of advanced breast cancer or metastatic breast cancer overexpressing HER2 (ErbB2). TN Tyverb.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.